SCHEMBL1425516

SCHEMBL1425516

CCOC(=O)N1Cc2nc(N)nc(OCc3cc(Br)ccc3Cl)c2C1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 1/20 0.36
HSP90AA1 P07900 8/20 0.36
HSP90AB1 P08238 7/20 0.36
MAPT P10636 3/20 0.35
HTT P42858 2/20 0.35
MAPK1 P28482 1/20 0.35
PTGER1 P34995 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
MPI P34949 1/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CCR5 P51681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1425497 0.89 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTPTGER1KMT2A
SCHEMBL12811648 0.89 HSP90AA1 (0.35) HSP90AA1HSP90AB1PTGER1
SCHEMBL1425623 0.84 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10HSP90AA1HSP90AB1
SCHEMBL1425564 0.81 KDM5A (0.39) ALDH1A1HSD17B10HSP90AA1HSP90AB1
SCHEMBL12811838 0.78 ALDH1A1 (0.40) ALDH1A1KDM4EPTGER1KMT2AMEN1
SCHEMBL1426147 0.78 MAPK1 (0.39) ALDH1A1KDM4EHSD17B10HSP90AA1HSP90AB1
SCHEMBL1426475 0.76 SMN1; SMN2 (0.40) ALDH1A1HSD17B10HSP90AA1HSP90AB1MAPT
SCHEMBL3304147 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EHSP90AA1HSP90AB1MAPT
SCHEMBL1425991 0.74 ALDH1A1 (0.42) ALDH1A1MAPTHTTMAPK1KMT2A
SCHEMBL1425480 0.74 KDM4E (0.38) ALDH1A1KDM4EHSP90AA1HSP90AB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118111-B1 2-AMIN0-5, 7-DIHYDR0-6H- PYRROLO [3, 4-D] PYRIMIDINE DERIVATIVES AS HSP-90 INHIBITORS FOR TREATING CANCER PFIZER (US) 2011-03-23 EP disclosed
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS PFIZER INC. 2010-04-15 US disclosed
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS PFIZER INC. 2010-04-15 US disclosed
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS PFIZER INC. 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS HSP90AB2P, HSP90AB1, HSP90AA1 ALDH1A1 771/4885KDM4E 3595/4885HSD17B10 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.